Author:
Li C.,Fleisher D.,Li L.,Schwier J.R.,Sweetana S.A.,Vasudevan V.,Zornes L.L.,Pao L.-H.,Zhou S.Y.,Stratford R.E.
Reference28 articles.
1. Semisynthetic chemical modification of the antifungal lipopeptide Echinocandin B (ECB):Structure–activity studies of the lipophilic and geometric parameters of polyarylated acyl analogs of ECB;Debano;J Med Chem,1995
2. Anti‐pneumocystis activity of LY303366 and other Echinocandin B analogs;Current,1993
3. Echinocandin antifungal agents;Turner,1997
4. LY303366 Clinical Investigation Brochure, Clinical Pharmacology Section. 1996. Section 8, p 3.
5. Ponsler GD, McMillian CL. 1996. Relative oral bioavailability of 250 mg of LY303366 in male beagle dogs after fasting, feeding or pretreatment with nizatidine (5 mg/kg) [Study 030D95]. Internal Report: ADME Report 15.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献